Activated g protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulationof mitogen-activated protein kinase - Resultant effects on cell proliferation
La. Sellers et al., Activated g protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulationof mitogen-activated protein kinase - Resultant effects on cell proliferation, J BIOL CHEM, 274(23), 1999, pp. 16423-16430
The peptide hormone somatostatin exhibits antipro liferative activity by in
teracting with the G protein-coupled sst, or sst, receptor types. We show h
ere that somatostatin at the human recombinant sst, receptor induced a conc
entration-dependent increase in proliferation (EC50 20 nM) with a maximal r
esponse 5-fold greater than that produced by its synthetic analog, L-362,85
5. Analysis of the phosphorylation status of extracellular signal-regulated
kinase (ERK)1 and ERK2 showed temporal differences in the changes evoked b
y the agonists, Phosphorylation induced by somatostatin (100 nM) peaked 10
min after the application and produced a response that continued for at lea
st 4 h. In contrast, L-362,855 (1 mu M) showed transient phosphorylation th
at had declined to basal levels by I h, However, both agonists induced rapi
d and sustained tyrosine phosphorylation of signal transducer and activator
of transcription 3 (STAT3) which was pertussis toxin-insensitive. Serine p
hosphorylation of STAT3 was only apparent after somatostatin treatment and
was abolished by pertussis toxin or PD 98059, together with the associated
increases in proliferation. Mitogen-activated protein/ERK kinase-1 inhibiti
on also decreased the time interval over which somatostatin-induced ERK pho
sphorylation was observed (<2 h), We conclude that the difference in the ma
gnitude of the proliferative response evoked by the two agonists at the sst
(4) receptor can be accounted for by their differential ability to phosphor
ylate STAT3 on serine residues and supports the concept that selective sign
aling can be achieved through pharmacological diversity.